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Treatment/Prevention 
Ebola, a Deadly Viral Disease affecting the West African Country of Sierra Leone 
Unisa Seisay RN, BS, MSN Student 
Introduction 
Presently, there has been 
an outbreak of Ebola 
Virus Disease (EVD) in the 
West African countries of 
Sierra Leone, Liberia, 
Nigeria, Senegal and 
Guinea. The outbreak 
was first discovered in 
Guinea in March 21, 
2014 and has spread to 
the neighboring 
countries. This has 
resulted in a lot of 
fatalities and is now 
considered a global 
public health concern 
(WHO, 2014).  
 
* Sierra Leone (SL) with 
a population of 6 million 
people recorded first 
case in May, 2014. 
 
As of November  9 , 
2014 according to MHS- 
Sierra Leone… 
• 4, 435 confirmed 
cases. 
• 1, 133 confirmed 
deaths. 
• 897 total survival 
and released 
patients. 
• According to WHO, 
outbreak is on the 
increased. 
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Signs & Symptoms Background 
SL is unable to 
contain the disease. 
They lack basic 
infrastructures and 
personnel to handle 
outbreak. 
• Fewer 
Health/Medical 
Amenities 
• Fewer Doctors, 
Nurses, and other 
health care 
professionals. 
• 5 Laboratories 
/testing centers in 
whole country. 
• One of poorest in the 
world & experience a 
decade old civil war. 
• Lower education rate 
& high poverty 
• High cultural beliefs 
and practices 
Lose of healthcare 
workers in SL is 
tremendous. 
• Lost 4 doctors 
including Dr. Sheik 
Khan, specialist in 
Viral hemorrhagic 
fever & Director of 
Lassa Fever Center in 
Kenema. 
• Lost of  7 nurses in a 
single treatment 
center in Kenema. 
• Lost of half the 
population in a 
Village in Bombali 
  
Ebola is a virus that causes 
high fever and severe 
headache, malaise, 
vomiting, diarrhea and 
abdominal pain. 
• 30-50% of patients 
shows hemorrhage 
symptoms. 
• Leads to multiple 
organ failures. 
• Septic shock & deaths 
• 2-21 days Incubation 
period, 8 – 10 days 
when signs & 
symptoms most 
visible & transmitted. 
• Laboratory testing 
done by blood test and 
results confirmed in 
few days. 
• 1 in 5 infections occur 
during victim burial & 
death (WHO, 2014). 
 Otterbein University, Westerville, Ohio  
Chart showing cumulative death as of November 4, 2012. (WHO, 2014) 
Implications 
Speed-up response in 
case management, 
surveillance & contact 
tracing, facilitating 
laboratory service, 
providing safe burials & 
optimizing social 
mobilization (WHO, 
2014 & Agyepong, 
2014) 
• Increase in testing 
centers. 
• Improving burial 
time within 24 
hours 
• Increase number of 
healthcare workers. 
• Financial and 
economic 
assistance. 
 
Conclusion 
• SL in state of 
emergency. 
• Many districts and 
regions in lockdown 
or quarantine. 
• No schooling & public 
gathering 
• Non-essential 
government workers 
stay at home. 
• Economic cost 
devastating  – people 
depend on aid 
services. 
• Human loss 
unbearable. Lost of 
whole families. 
• Sense of helplessness. 
 
 
 
Problems 
The disease is caused by the virus family Filoviridae and five species have been 
identified. The species that has been causing this outbreak in Sierra Leone is the Zaire 
ebolavirus. Fruit bats are widely known to be the natural reservoir or host of the Ebola 
virus. Ebola is transmitted from human to human through direct contact through bodily 
fluids which include blood, semen, urine, stool, sweats or secretions or parenterally 
from an infected person or dead body. People also can become infected by direct 
contact with the virus through surfaces and contaminated clothing/bedding (Feldmann 
et al, 2011 & WHO, 2014). People can be infected by disease through eating infected 
animal. 
The virus enters the host through broken skin mucosal surfaces. The virus targets 
monocytes, macrophages, dendritic cells, endothelial cells, fibroblasts, adrenal corticol 
cells, hepatocytes, and other epithelial cells which causes them to replicate and become 
infectious. Then, they are transported through the lymphatic system, to the liver and 
the spleen via blood. It spreads the infection to different organs and parts of the body.  
EVD suppresses the immune system and triggers inflammatory response that inhibits 
vascular coagulation which leads to multiple organ dysfunction and death (Fowler et al, 
2014, CDC, 2014, & Feldmann et al, 2011). 
Pathophysiology & Significance 
       The disease has shown a low level of hemoglobin and hypoxia in a person infected 
with the virus. Also, reduced white blood cell (WBC) and platelet counts, proteinuria, and 
increased liver enzymes have been found in an infected person. Because of similarities in 
symptoms with malaria, typhoid fever and meningitis, Ebola is very difficult to distinguish 
with clinical symptoms. Laboratory testing is therefore significant in confirming the 
diagnosis of the disease. Laboratory testing for Ebola includes antibody-capture enzyme-
linked immunosorbent assay (ELISA), antigen-capture detection tests, serum 
neutralization test, reverse transcriptase polymerase chain reaction (RT-PCR) assay, 
electron microscopy, and virus isolation be cell culture. The incubation period with Ebola 
virus is 2 to 21 days and infected individuals cannot transmit the disease until they 
develop the symptoms. In Sierra Leone, the most common symptoms with this outbreak 
are hemorrhagic fever and gastrointestinal symptoms (nausea, anorexia, abdominal 
discomfort). These symptoms are followed by diarrhea and vomiting which then lead to 
intravascular depletion and complications. The complications include electrolyte 
imbalances, hypoperfusion, disseminated intravascular coagulation (DIC), shock, and 
gastrointestinal bleeding (WHO, 2014, Feldmann et al, 2011, & CDC, 2014). 
A map above from CDC is showing levels of transmission and Ebola treatment Units. 
There is no 
treatment or vaccine 
for EVD and 
supportive care is the 
only option. 
• Providing IV fluids. 
• Improve Nutrition. 
• Maintaining 
electrolytes 
• Treat other 
infections, pain, 
and anxiety. 
Proper use of PPE, 
hand washing and use 
of sanitizers or 
decontaminate is 
essential in controlling.  
 
 
